Epigenomics Files Third Module of PMA to FDA for Colon Cancer Test
June 12, 2012
Epigenomics Files Third Module of PMA to FDA for Colon Cancer Test
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- MDx/CDx Focus: Austin Breast Center Offers BrevaGen; Epigenomics Studies Colon Cancer MDx vs FIT
April 11, 2012 / Pharmacogenomics Reporter - Qiagen Building Sample-Prep Tech for Colorectal Cancer Test Under Epigenomics Option
March 3, 2011 / PCR Insider - Epigenomics Taps Pronto Diagnostics as Israeli Distributor for Colorectal Cancer Dx
October 14, 2010 / PCR Insider - NextPharma Deal Next Step Toward US Distribution of Epigenomics' Colon Cancer Dx
October 7, 2010 / PCR Insider - ARUP Launches Blood-Based LDT for Colorectal Cancer in US Based on Epigenomics' Septin9 Biomarker
July 22, 2010 / PCR Insider